Biogen Inc (BIIB)

Add to Watchlists
Create an Alert
232.03 -1.15  -0.49% NASDAQ Aug 22, 16:59 Delayed 2m USD

Biogen Cash from Investing (TTM):

-2.116B for June 30, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Investing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Investing (TTM) Data

View and export this data going back to 1984. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2019 -2.116B
March 31, 2019 -3.154B
Dec. 31, 2018 -2.046B
Sept. 30, 2018 -1.190B
June 30, 2018 -1.818B
March 31, 2018 -872.30M
Dec. 31, 2017 -2.963B
Sept. 30, 2017 -2.775B
June 30, 2017 -1.492B
March 31, 2017 -2.026B
Dec. 31, 2016 -2.485B
Sept. 30, 2016 -3.711B
June 30, 2016 -4.737B
March 31, 2016 -5.254B
Dec. 31, 2015 -4.554B
Sept. 30, 2015 -3.124B
June 30, 2015 -2.675B
March 31, 2015 -2.052B
Dec. 31, 2014 -1.543B
Sept. 30, 2014 -1.875B
June 30, 2014 -1.659B
March 31, 2014 -1.755B
Dec. 31, 2013 -1.605B
Sept. 30, 2013 -1.270B
June 30, 2013 -1.468B
   
March 31, 2013 -795.02M
Dec. 31, 2012 -950.34M
Sept. 30, 2012 -964.42M
June 30, 2012 -1.029B
March 31, 2012 -1.523B
Dec. 31, 2011 -1.650B
Sept. 30, 2011 -1.779B
June 30, 2011 -1.262B
March 31, 2011 -31.21M
Dec. 31, 2010 345.32M
Sept. 30, 2010 1.247B
June 30, 2010 841.89M
March 31, 2010 -53.59M
Dec. 31, 2009 -395.03M
Sept. 30, 2009 -1.243B
June 30, 2009 -868.45M
March 31, 2009 -907.16M
Dec. 31, 2008 -365.87M
Sept. 30, 2008 -516.75M
June 30, 2008 -483.93M
March 31, 2008 330.39M
Dec. 31, 2007 -286.57M
Sept. 30, 2007 266.38M
June 30, 2007 454.52M
March 31, 2007 -494.94M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Advertisement

Cash from Investing (TTM) Benchmarks

Benchmarks
Amgen Inc 2.795B
Celgene Corp -970.00M
Gilead Sciences Inc -1.393B

Cash from Investing (TTM) Range, Past 5 Years

Minimum -5.254B Mar 2016
Maximum -872.30M Mar 2018
Average -2.623B

Cash from Investing (TTM) Excel Add-In Codes

  • Metric Code: cash_investing_ttm
  • Data Point Example: =YCP("BIIB", "cash_investing_ttm")
  • Data Series Example: =YCS("BIIB", "cash_investing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.